Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the way to finalize Phase 3 protocol and recruit sites for U.S.
The UK Food Standards Agency (FSA) has selected eight companies to participate in a two-year regulatory programme focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback